City

Barcelona (1)

Madrid (1)

Milan (1)

New Orleans (1)

Rozzano (1)

Condition

Bladder Carcinoma in Situ (CIS) (2)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Fidia Farmaceutici s.p.a. (2)

Collaborator

Intervention

oncofid p-b (paclitaxel-hyaluronic acid) (1)

oncofid-p-b™ (paclitaxel-hyaluronic acid) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

bladder carcinoma in situ (cis)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Bladder Carcinoma in Situ (CIS) Trial (ONCOFID P-B (PACLITAXEL-HYALURONIC ACID))

Recruiting

Bladder Carcinoma in Situ (CIS)

ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)

New Orleans, Louisiana

Ochsner Clinic Foundation

Jan 18, 2023

Bladder Carcinoma in Situ (CIS) Trial in Italy, Spain (ONCOFID-P-B™ (PACLITAXEL-HYALURONIC ACID))

Completed

Bladder Carcinoma in Situ (CIS)

ONCOFID-P-B™ (PACLITAXEL-HYALURONIC ACID)

Milan, Mi, Italy
+4 more

Mar 13, 2021